Christopher Robinson/LinkedIn
Jul 12, 2026, 15:56
Christopher Robinson: Nipocalimab Compared With IVIG and Prednisone in FNAIT-Risk Pregnancies
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia.”
Title: Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Authors: James Bussel, Barbara Stegmann, Pamela Baker, Abbie Oey, Yanxin Jiang, Rebecca Zaha, Hillary Van Valkenburgh, Babajide Keshinro
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 4, 2026, 17:17Dan Annetts: The Fabulous CREATE Fertility Bristol Team This Week
-
Sep 4, 2026, 17:15Arsiak Vartenian: The Question I Wish Fertility Clinics Asked Women More…
-
Sep 4, 2026, 17:13Zeynab Kazemianpour: 2 Unusual Oocytes Observed Before ICSI
-
Sep 4, 2026, 17:11Saff Mitten: Do You Ever Worry Your Friends Are Getting Bored of Your Long IVF Journey?
-
Sep 4, 2026, 17:04David Pening: New Article on the Genetic Landscape of Acephalic Spermatozoa Syndrome
-
Sep 4, 2026, 16:55Blessed Obediran: The Science of Donor Conception Is Easy, The Harder Questions Are the Ethical Ones
-
Sep 4, 2026, 16:51Delighted to Welcome a Team of Colleagues from St. Gallen, Switzerland – Brussels IVF
-
Sep 4, 2026, 16:48Vikrant Bhatia: In Fertility Care, More Information Doesn’t Always Mean Better Decisions
-
Sep 4, 2026, 16:46Priyadatt Patel: Few Numbers Cause as Much Unnecessary Distress as AMH
